BROOKLYN, NY – June 08, 2018 – ACROBiosystems andCMP Scientific today announced that the companies have entered into a strategic collaboration in CE-MS sample analysis services. The companies will co-develop monoclonal antibody charge variants sample analysis services and explore the feasibility of integrated workflow using the recombinant protein ligands from ACROBiosystems for biotherapeutics in vivo pharmacokinetic and drug metabolism analysis using CMP Scientific’s EMASS-II CE-MS technology.
The EMASS-II CE-MS interface was introduced by CMP Scientific in 2015 and has been adopted by many leading biopharmaceuticals companies for a variety of applications including monoclonal antibody (mAb) intact mass analysis, impurity profiling, charge variants characterization, subunit analysis, peptide mapping, biosimilar comparisons and biotransformation studies. This interface is also being used at several life science research institutes around the world for metabolite analysis, nucleic acid analysis and polysaccharide analysis.
"Our collaboration with CMP Scientific leverages ACROBiosystems’ leadership in recombinant protein production and expands our capabilities in product characterization utilizing CMP’s advanced CE-MS technology," said Mike Chen, Founder and CEO of ACROBiosystems. "Through this collaboration, we are poised to provide our global biopharma clients CE-MS based methods development and value-added services.”
“ACROBiosystems is well recognized in the biopharma industry for its quality of recombinant protein products and services.” said James Xia, CEO of CMP Scientific. “By utilizing CMP’s advanced CE-MS technology platform, ACROBiosystems will be able to offer its biopharma customers analytical services to help solve many of the analytical challenges faced by biopharma researchers.”
About ACROBiosystems: ACROBiosystems is an internationally recognized manufacturer of recombinant proteins committed to supporting pharmaceutical industry. Its high-quality proteins have been widely used in the process of therapeutic drug development from immunization, antibody screening, to pre-clinical and clinical assay development. The introduction of the Innovation Lab Delaware Innovation Space in Wilmington Delaware provides the right blend of innovation and technology and valued-added services that utilize a variety of platform technologies.
About CMP Scientific Corp: CMP Scientific is a global analytical instrument company with advanced, proprietary Capillary Electrophoresis – Mass Spectrometry (CE-MS) technologies. CMP Scientific develops and markets CE-MS ion sources for ESI mass spectrometers and provides applications, consumables and method development services to help researchers utilize CE-MS to solve many challenging analytical problems.